Maryland Oncology Hematology, P.A.

Clinton, Maryland 20735

0 studies enrolling now · 6 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, Cancer, ITP, Immune Thrombocytopenia, KRAS p, G12c Mutated /Advanced Metastatic NSCLC, Metastatic Breast Cancer, Neoplasms, Non-Small Cell Lung Cancer, TNBC - Triple-Negative Breast Cancer

Studies at this site

• Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200). — Completed
• Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• Palbociclib in Real World Practice — Completed
• Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC) — Completed
• Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy — Stopped early
• The Circulating Cell-free Genome Atlas Study — Status unconfirmed